Marc Beer, an expert in development and commercialisation of biotechnology, pharmaceutical, devices and diagnostics, has contributed $42 M to support women`s health. He founded Renovia Inc. together with Ramon Iglesias, Yolanda Lorie and MD in 2016 and successfully closed a series A financing with the leading healthcare investment capital funds. Marc Beer is also the Chairman and Chief Executive Officer of this Boston based Medtech Company.
Renovia Inc. has been operational since its establishment producing products for treating pelvic floor disorders which include urinary incontinence. According to researches carried out, it is estimated that about 250 million women globally suffer from pelvic floor disorders. Leva, which is the first product from Renovia received FDA approval on April 2018.
The money raised was to be used in financing programs to develop four more therapeutic and diagnostic products as well as improvising new products of Leva devices. The financing was led by New York-based Perceptive Advisors, Ascension Ventures from Missouri and the Longwood Fund, a healthcare-focused investment firm which had also previously invested in series A.
Marc Beer on behalf of Renovia Inc. management team appreciated the support they had been receiving from these healthcare investors who had a similar goal of helping and improving lives of women suffering from pelvic floor disorders in the world. He added that through combining innovative skills and proprietary technologies will help the company develop a new digital platform. The digital platform aims at providing valuable information to all patients on the new diagnostic and treatments offered by Marc Beers Company at relatively low costs.
Marc Beer has received many awards for being a good leader and for his efforts to improve the health industry. Renovia Company is made up of a group of experts who foresee its development and growth. Some of the leader who work alongside Marc Beer include; William Dull who is the Chief Commercial officer, Dr. Samantha Pulliam, MD the Chief Medical Officer, Jose Bohorquez, PhD the Chief Scientific Officer and Jessica McKinney, PT, MS, CMPT who serves as the Vice president of all medical affairs and even Clinical Advocacy.
Before joining Renovia, Marc Beer was the founder of ViaCell Company that specializes with collection and preservation of blood stem cells for the umbilical cord. He has also served in various organizations related to health industry including NASDAQ a publicly traded biopharmaceutical Company. While working at Genzyme Marc Beer promoted the establishment of multiple products that addressed numerous diseases. Working at these companies earned Marc Beer different experiences. Marc Beer is a member of the Notre Dame Graduate Studies Research and the advisory council. Learn more: https://renoviainc.com/leadership/